Cardiff Oncology, Inc. (CRDF)

Typically moves ±10.22% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Cardiff Oncology, Inc. (CRDF) has a 21-report earnings history dating back to May 06, 2021. Its average absolute post-earnings move is ±10.22%, and 52.4% of those reactions were positive. Its largest post-earnings gain was +64.41% (Feb 29, 2024) and its largest decline was -24.77% (Jul 29, 2025). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How CRDF moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±10.22%

Positive %

52.4%

Negative %

47.6%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☽ POST	-3.83%	open_in_new
May 14, 2026	☽ POST	-3.49%	open_in_new
Nov 06, 2025	☽ POST	-2.67%	open_in_new
Jul 29, 2025	☽ POST	-24.77%	open_in_new
May 08, 2025	☽ POST	+1.14%	open_in_new
Feb 27, 2025	☽ POST	+4.43%	open_in_new
Nov 07, 2024	☽ POST	-24.69%	open_in_new
Aug 08, 2024	☽ POST	+11.74%	open_in_new
May 02, 2024	☽ POST	-21.43%	open_in_new
Feb 29, 2024	☽ POST	+64.41%	open_in_new
Nov 02, 2023	☽ POST	-2.63%	open_in_new
Aug 09, 2023	☽ POST	+8.38%	open_in_new
May 04, 2023	☽ POST	-3.59%	open_in_new
Mar 02, 2023	☽ POST	+1.73%	open_in_new
Nov 03, 2022	☽ POST	+0%	open_in_new
Aug 04, 2022	☽ POST	+4.55%	open_in_new
May 05, 2022	☽ POST	-1.49%	open_in_new
Feb 24, 2022	☽ POST	+7.49%	open_in_new
Nov 04, 2021	☽ POST	-4.93%	open_in_new
Aug 05, 2021	☽ POST	+11.84%	open_in_new
May 06, 2021	☽ POST	+5.33%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±10.22%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 20 →

Funds holding

$8098089

Total value held

Selling

6 added · 10 reduced

Pfizer Inc

$3014469 Held

Franklin Resources Inc

$1567544 Held

Blackrock, Inc.

$1264735 -75.56%

Ubs Group Ag

$830309 NEW BUY

State Street Corp

$430814 -72.08%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
DEF 14A	20260826	open_in_new SEC.gov
DEFA14A	20260826	open_in_new SEC.gov
PRE 14A	20260814	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
SCHEDULE 13G/A	20260727	open_in_new SEC.gov
S-8	20260721	open_in_new SEC.gov
424B5	20260716	open_in_new SEC.gov
4	20260716	open_in_new SEC.gov
4	20260716	open_in_new SEC.gov

Frequently asked about CRDF earnings

When does Cardiff Oncology, Inc. report earnings next? expand_more

Cardiff Oncology, Inc. (CRDF)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CRDF stock move after earnings? expand_more

Over 21 reports, CRDF has moved an average of ±10.22% the session after earnings, closing higher 52.4% of the time.

What was CRDF's biggest post-earnings move? expand_more

CRDF's largest post-earnings gain on record was +64.41% on Feb 29, 2024, and its largest decline was -24.77% on Jul 29, 2025.

Where can I find Cardiff Oncology, Inc.'s SEC filings? expand_more

All of Cardiff Oncology, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.